A 62-year-old man with chronic kidney disease (eGFR 28 mL/min/1.73m²) is prescribed gentamicin for a suspected gram-negative sepsis. After 5 days of therapy, he develops high-frequency sensorineural hearing loss and vertigo. Which investigation is most appropriate to confirm aminoglycoside-induced ototoxicity?